- Home
- MRM vs NVNO Comparison
MRM vs NVNO Comparison
Compare MRM & NVNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRM
- NVNO
- Stock Information
- Founded
- MRM 2000
- NVNO 1987
- Country
- MRM Japan
- NVNO United States
- Employees
- MRM N/A
- NVNO N/A
- Industry
- MRM Other Consumer Services
- NVNO Medical/Dental Instruments
- Sector
- MRM Consumer Discretionary
- NVNO Health Care
- Exchange
- MRM Nasdaq
- NVNO Nasdaq
- Market Cap
- MRM 16.0M
- NVNO 16.7M
- IPO Year
- MRM 2020
- NVNO N/A
- Fundamental
- Price
- MRM $2.15
- NVNO $0.70
- Analyst Decision
- MRM
- NVNO
- Analyst Count
- MRM 0
- NVNO 0
- Target Price
- MRM N/A
- NVNO N/A
- AVG Volume (30 Days)
- MRM 2.1M
- NVNO 316.7K
- Earning Date
- MRM 05-22-2026
- NVNO 10-31-2025
- Dividend Yield
- MRM N/A
- NVNO N/A
- EPS Growth
- MRM N/A
- NVNO N/A
- EPS
- MRM 0.04
- NVNO N/A
- Revenue
- MRM $55,915,220.00
- NVNO N/A
- Revenue This Year
- MRM N/A
- NVNO N/A
- Revenue Next Year
- MRM N/A
- NVNO N/A
- P/E Ratio
- MRM $61.67
- NVNO N/A
- Revenue Growth
- MRM 12.79
- NVNO N/A
- 52 Week Low
- MRM $0.34
- NVNO $0.67
- 52 Week High
- MRM $4.45
- NVNO $5.62
- Technical
- Relative Strength Index (RSI)
- MRM 48.12
- NVNO 30.73
- Support Level
- MRM $2.07
- NVNO $0.68
- Resistance Level
- MRM $2.73
- NVNO $0.74
- Average True Range (ATR)
- MRM 0.21
- NVNO 0.05
- MACD
- MRM -0.04
- NVNO 0.03
- Stochastic Oscillator
- MRM 22.07
- NVNO 13.67
About MRM MEDIROM Healthcare Technologies Inc.
MEDIROM Healthcare Technologies Inc provides health services. The company is a franchiser and operator of healthcare salons and operates in segments namely Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty Segment. The company generates a majority of its revenue from the Relaxation Salon business segment. Geographically, the company generates a maximum share of its revenue from Japan.
About NVNO enVVeno Medical Corporation
enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.